Status:
RECRUITING
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Lead Sponsor:
Sophia Koutsogiannaki
Conditions:
Lung Injury
Cardiopulmonary Bypass
Eligibility:
All Genders
Up to 12 years
Brief Summary
Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study i...
Detailed Description
Acute lung injury (ALI) is frequently associated with the use of extracorporeal circulation during cardiopulmonary bypass (CPB) surgery and develops postoperatively in 2-3% of cardiac surgical patient...
Eligibility Criteria
Inclusion
- Are \< 12months of age
- Scheduled for cardiac surgical needing CPB
- Preoperative SpO2 \> 90%
Exclusion
- Lack of parental (or legal guardian's) consent
- Preoperative SpO2 \< 90%
- Preoperative oxygen therapy
Key Trial Info
Start Date :
October 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04296071
Start Date
October 14 2022
End Date
December 1 2026
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115